Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation

SAN DIEGO, Sept. 19 (Korea Bizwire) — Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release and first shipment of the BioXp™ 9600 system, a next-generation high throughput platform designed to revolutionize synthetic biology workflows. The latest instrument further accelerates the design-build-test process of research and discovery by [...]